Grip Strength (L+R) Test

How hard you can squeeze a handle says a surprising amount about how long you will live and how well you will function as you age. Across hundreds of thousands of adults, lower grip strength tracks with higher risk of heart disease, cancer, diabetes, dementia, and earlier death, often more strongly than blood pressure does.

Testing both hands gives you the most useful number. About one in three adults is actually stronger with their non-dominant hand, so checking only one side can underestimate your true capacity and miss meaningful left-right imbalances that carry their own risk signal.

What HGS (handgrip strength) Actually Measures

A grip test uses a handheld device called a dynamometer to record peak squeeze force in kilograms or pounds. Standard protocol is three trials per hand with the best value kept for each side. The combined L+R reading captures the integrated function of your forearm and hand muscles, the motor nerves driving them, and the brain circuits coordinating the effort.

Although the test happens in your hand, the number reflects something much bigger. Grip strength correlates closely with the strength of other major muscle groups and serves as a stand-in for whole-body muscular fitness, which is why researchers describe it as a systems-level read on your physical reserve rather than a hand-specific measurement.

Why a Squeeze Test Predicts So Much

Genetic studies link grip strength loci to genes governing muscle fiber structure and the maintenance of motor neurons, placing the test at the intersection of muscle and nervous system biology. Proteomic work (large-scale measurement of circulating proteins) shows that people with higher grip strength carry more favorable patterns of proteins tied to inflammation and immune signaling, partially mediating the connection between grip strength and healthy aging.

Grip strength also tracks nutritional status, metabolic health, and chronic inflammation. That is why it captures information that no single blood test does: it integrates muscle quality, neurological function, recovery capacity, and the cumulative wear of disease into one number you can produce in 30 seconds.

All-Cause Mortality

In the PURE study of 139,691 adults across 17 countries, grip strength was a stronger predictor of all-cause and cardiovascular death than systolic blood pressure. A dose-response meta-analysis covering more than 3 million participants found that higher grip strength was consistently linked to lower mortality from all causes, cancer, and cardiovascular disease.

In the UK Biobank study of about half a million adults, lower grip strength tracked with higher risk of dying from any cause, with the relationship holding even after accounting for age, sex, body size, smoking, blood pressure, and other conventional risk factors.

Heart Disease Risk

A pooled analysis of patients with cardiac conditions found that lower grip strength independently predicted cardiac death, all-cause death, and hospital admission for heart failure. In a UK Biobank analysis of 347,130 adults, higher grip strength was tied to lower risk of adverse cardiovascular outcomes, and the protective signal was especially useful for identifying higher-risk subgroups among people with diabetes.

Adding grip strength to standard office-based cardiovascular risk scores improved their accuracy by an amount comparable to adding HDL cholesterol or NT-proBNP (a heart-strain marker), making it a meaningful addition to risk assessment rather than a redundant one.

Type 2 Diabetes and Metabolic Health

In a UK Biabank cohort of 166,894 adults, lower grip strength was associated with a higher risk of developing type 2 diabetes in both men and women, with stronger associations when grip strength was expressed relative to body weight. Among 4,221 U.S. adults, higher relative grip strength tracked with better cardiometabolic profiles, including lower blood pressure, triglycerides, fasting glucose, and insulin, and higher HDL.

Among normotensive U.S. adults, grip strength normalized to body weight discriminated diabetes risk well enough that researchers proposed it as a practical early-warning screen, particularly useful when full lab testing is not immediately available.

Cancer Risk and Prognosis

In 445,552 UK Biobank participants, lower absolute grip strength was inversely linked to risk of several site-specific cancers, including breast, colorectal, liver, gallbladder, kidney, and endometrial cancer, as well as overall cancer incidence. Among adults already diagnosed with advanced cancer, reduced maximal grip strength predicted higher mortality and worse functional status, with cut points of less than 25.1 kg in women and less than 40.2 kg in men flagging poor 2-year survival.

Cognitive Decline and Dementia

A meta-analysis of longitudinal cohort studies found that poorer baseline grip strength roughly doubled the risk of future cognitive decline and increased the risk of dementia, including both Alzheimer and non-Alzheimer types. In dementia-free middle-aged and older adults, lower grip strength was associated with higher plasma levels of tau, a protein marker tied to neurodegeneration, suggesting the test picks up something about brain aging long before symptoms appear.

Kidney, Liver, and Other Organ Disease

In a Chinese multicenter cohort of 4,618 middle-aged and older adults, lower combined left and right grip strength was associated with higher risk of new-onset chronic kidney disease. Lower grip strength has also been linked to non-alcoholic fatty liver disease, with insulin resistance and inflammation explaining only a small portion of the connection.

The Asymmetry Signal

Bilateral testing exposes a second layer of information beyond the absolute number: the difference between your two hands. Asymmetry is typically defined as more than a 10% gap between sides. In a U.S. study of 18,468 aging Americans, asymmetry combined with weakness was associated with higher odds of future disability in basic daily activities.

In a separate analysis of 19,325 aging Americans, asymmetry and weakness independently accelerated time to death, with weakness carrying the stronger signal. In 512 geriatric outpatients, having both low and asymmetric grip strength tripled the risk of frailty compared with neither finding.

Reference Ranges

Grip strength varies by age, sex, body size, country, and the device used, so any single number is best interpreted against your own baseline and against population norms for your demographic. The values below come from large national studies and are illustrative orientation, not universal targets. Your testing center may report different numbers depending on the dynamometer model and protocol.

What this means for you: grip strength peaks around age 30 to 40 and declines from midlife onward. By age 80, weak grip strength is present in about 23% of men and 27% of women in pooled British data. Compare your result to age- and sex-matched norms from the same testing protocol whenever possible.

When Results Can Be Misleading

Grip strength is reliable when measured well, but a single reading can be skewed by short-term factors that have nothing to do with your underlying health.

• Recent intense exercise: After a national bouldering championship, elite climbers showed about a 6.4% drop in maximal grip strength at 12 hours, with values returning to baseline by 24 hours. Heavy upper-body work in the day before testing can produce an artificially low reading.
• Recent surgery or hospitalization: In older adults undergoing elective major surgery, grip strength declined meaningfully over a roughly 15-day stay. Testing in the immediate post-operative window will not reflect your usual capacity.
• Device and protocol differences: The Jamar hydraulic, JamarSmart, and Martin Vigorimeter dynamometers give somewhat different numbers and are not always interchangeable. Compare results from the same device and protocol over time.
• Acute hand or wrist pain: Active injury, joint flares, or recent trauma to either hand will lower the result on that side without reflecting whole-body muscle health.

Medications That Can Lower Grip Strength

Some commonly prescribed drugs are linked to reduced grip strength as a side effect. In a cohort of 2,087 older adults, anticholinergic medicines were associated with about 1.4 kg lower grip in women, and sedatives were associated with about 1.9 kg lower grip in men. In the Hertfordshire Cohort Study of 2,987 older adults, certain cardiovascular drugs, including furosemide and nitrates, were tied to lower grip strength.

In a UK Biobank analysis of 297,977 adults, continuous statin use was associated with a decline in muscle function and mass over time, regardless of genetic susceptibility to statin response. Psychotropic medications have also been linked to reduced grip strength in older hospitalized adults.

Tracking Your Trend

A single grip strength reading is most useful when interpreted against your own past values and the trajectory between them. Test-retest research in healthy adults shows that grip strength has good to excellent reliability, and 1-year reproducibility is better than longer intervals, which makes annual or more frequent testing the practical sweet spot.

Get a baseline now, retest in 3 to 6 months if you are starting a strength training program or recovering from illness, and then at least annually after that. The trajectory matters more than any single number: a stable or rising trend is reassuring even at modest absolute values, and a downward slope is meaningful even if your number still falls within population norms.

What to Do With an Abnormal Result

If your grip strength is below age- and sex-matched norms, or if you have a meaningful left-right asymmetry combined with weakness, treat it as a signal worth investigating rather than a diagnosis. Repeat the test on a different day with the same device to rule out a bad reading.

A persistently low result is a reason to look at the broader picture: full body composition (DXA-derived lean mass and skeletal muscle index), cardiometabolic labs (fasting glucose, HbA1c, lipids, hs-CRP), and a frailty or functional assessment if you are over 65. If grip strength has dropped sharply over a short interval, especially alongside unintended weight loss or fatigue, that pattern warrants a structured workup with a physician familiar with sarcopenia and frailty.